<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02446444</url>
  </required_header>
  <id_info>
    <org_study_id>ANZUP1303</org_study_id>
    <secondary_id>ACTRN12614000126617</secondary_id>
    <nct_id>NCT02446444</nct_id>
  </id_info>
  <brief_title>Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer</brief_title>
  <acronym>ENZARAD</acronym>
  <official_title>Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sydney</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Australian and New Zealand Urogenital and Prostate Cancer Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Health and Medical Research Council, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Trials Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TROG- Trans Tasman Radiation Oncology Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sydney</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of enzalutamide as part of
      adjuvant androgen deprivation therapy (ADT) with a luteinizing hormone releasing hormone
      analogue (LHRHA) in men having radiation therapy for localised prostate cancer at high risk
      of recurrence.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Stratification Factors:
Gleason score (&lt;=7 versus 8-10),
Regional lymph nodes involvement (N0 versus N1)
Clinical T-stage (T2 and below versus T3 and above),
PSA (&lt;20ng/mL versus ≥ 20ng/mL)
Study Site
Brachytherapy (yes versus no)
Pelvic Field (yes versus no)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival time</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cause-specific survival time</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prostate Specific Antigen (PSA) progression free survival time</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical progression free survival time</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to subsequent hormonal therapy (restarting ADT)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to castration-resistant disease (PCWG2 criteria)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metastasis-free survival (MFS)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events (CTCAE v4.03)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (EORTC Core Quality of Life Questionnaire (QLQC-30), Quality of Life Questionnaire for Prostate Cancer (PR-25), Euroqol 5 item preference-based measure of health (EQ-5 D-5L))</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health outcomes relative to costs (incremental cost effectiveness ratio)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <arm_group>
    <arm_group_label>Enzalutamide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enzalutamide 160 mg daily, by mouth, for 24 months from randomisation. All participants are treated with a LHRHA for 24 months from randomisation and external beam radiation therapy started approximately 16 weeks after randomisation (+/- brachytherapy boost)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Non-steroidal Anti-androgen (NSAA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Non-steroidal Anti-androgen (NSAA), by mouth, for 6 months from randomisation.
All participants are treated with a LHRHA for 24 months from randomisation and external beam radiation therapy started approximately 16 weeks after randomisation (+/- brachytherapy boost)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enzalutamide</intervention_name>
    <arm_group_label>Enzalutamide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Conventional NSAA</intervention_name>
    <arm_group_label>Conventional Non-steroidal Anti-androgen (NSAA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LHRHA</intervention_name>
    <arm_group_label>Enzalutamide</arm_group_label>
    <arm_group_label>Conventional Non-steroidal Anti-androgen (NSAA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>External Beam Radiotherapy (78 Gy in 39 fractions or 46 Gy in 23 fractions plus brachytherapy boost)</intervention_name>
    <arm_group_label>Enzalutamide</arm_group_label>
    <arm_group_label>Conventional Non-steroidal Anti-androgen (NSAA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Men with localised prostate cancer at high risk for recurrence deemed suitable for external
        beam radiation therapy.

        Inclusion Criteria:

          1. Pathological diagnosis of adenocarcinoma of the prostate, judged to be at high risk
             for recurrence based on any of the following (in accordance with the International
             Society of Urological Pathology (ISUP) Consensus 2005:

             Gleason score 8-10 OR Gleason score of 4+3 AND clinical T2b-4 AND PSA &gt;20ng/mL OR N1
             disease (involvement of lymph nodes at or below the bifurcation of the common iliac
             arteries) defined radiologically as greater than 10mm on short axis using standard CT
             or MRI, or biopsy proven

          2. Age ≥18 years

          3. Adequate bone marrow function Haemoglobin (Hb) ≥100g/L and White Cell Count (WCC) ≥
             4.0 x 109/L and platelets ≥100 x 109/L

          4. Adequate liver function: Alanine transaminase (ALT) &lt; 2 x ULN and bilirubin &lt; 1.5 x
             Upper Limit of Normal (ULN), (or if bilirubin is between 1.5 - 2 x ULN, they must have
             a normal conjugated bilirubin).

          5. Adequate renal function: calculated creatinine clearance &gt; 30 ml/min (Cockcroft-Gault)

          6. Eastern Cooperative Oncology Group (ECOG) performance status of 0-1

          7. Study treatment both planned and able to start within 7 days of randomisation.

          8. Willing and able to comply with all study requirements, including treatment, and
             attending required assessments

          9. Has completed the baseline HRQOL questionnaires UNLESS is unable to complete because
             of literacy or limited vision

         10. Signed, written, informed consent

        Exclusion Criteria:

          1. Prostate cancer with significant sarcomatoid or spindle cell or neuroendocrine small
             cell components

          2. Involvement of lymph nodes superior to the common iliac bifurcation, and/or outside
             the pelvis (distant lymph nodes). Lymph node involvement is defined by
             histopathological confirmation, or by a short axis measurement &gt;10mm on standard
             imaging (CT or MRI, but not PET).

          3. Any contraindication to external beam radiotherapy

          4. History of

               -  seizure or any condition that may predispose to seizure (e.g., prior cortical
                  stroke or significant brain trauma).

               -  loss of consciousness or transient ischemic attack within 12 months of
                  randomization

               -  significant cardiovascular disease within the last 3 months: including myocardial
                  infarction, unstable angina, congestive heart failure, ongoing arrhythmias of
                  Grade &gt; 2 , thromboembolic events (e.g., deep vein thrombosis, pulmonary
                  embolism). Chronic stable atrial fibrillation on stable anticoagulant therapy is
                  allowed.

          5. Evidence of metastatic disease: minimum imaging required Computed tomography scan (CT)
             / Magnetic Resonance Imaging (MRI) and Whole Body Bone Scan (WBBS). If equivocal bone
             scan, follow-up plain films are required to show NO evidence of cancer if not covered
             by CT/MRI

          6. PSA &gt; 100 ng/mL

          7. History of another malignancy within 5 years prior to randomisation except for
             non-melanomatous carcinoma of the skin; or, adequately treated, non-muscle-invasive
             urothelial carcinoma of the bladder (i.e. Tis, Ta and low grade T1 tumours).

          8. Concurrent illness, including severe infection that might jeopardize the ability of
             the patient to undergo the procedures outlined in this protocol with reasonable safety

               -  Human Immunodeficiency Virus (HIV)-infection is not an exclusion criterion if it
                  is controlled with anti-retroviral drugs that are unaffected by concomitant
                  enzalutamide.

          9. Presence of any psychological, familial, sociological or geographical condition
             potentially hampering compliance with the study protocol and follow-up schedule,
             including alcohol dependence or drug abuse;

         10. Patients who are sexually active and not willing/able to use medically acceptable
             forms of barrier contraception.

         11. Use of hormonal therapy or androgen deprivation therapy, including enzalutamide,
             except in the following setting:

               -  Use of LHRHA (with or without anti-androgens) for less than 30 days prior to
                  randomisation in the trial.

         12. Bilateral orchidectomy or radical prostatectomy

         13. Prior brachytherapy or other radiotherapy that would result in an overlap of
             radiotherapy fields

         14. Participation in other clinical trials of investigational agents for the treatment of
             prostate cancer or other diseases.

         15. Major surgery within 21 days prior to randomisation

         16. Known gastrointestinal (GI) disease or GI procedure that could interfere with the oral
             absorption or tolerance of enzalutamide, including difficulty swallowing tablets
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Williams</last_name>
    <role>Study Chair</role>
    <affiliation>ANZUP and Peter MacCallum Cancer Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Nguyen</last_name>
    <role>Study Chair</role>
    <affiliation>Dana Farber Cancer Institute and ANZUP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ENZARAD Trial Coordinator</last_name>
    <phone>02 9562 5368</phone>
    <email>enzarad@ctc.usyd.edu.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Vastola</last_name>
      <phone>617-525-3184</phone>
      <email>Marie_Vastola@DFCI.HARVARD.EDU</email>
    </contact>
    <investigator>
      <last_name>Paul Nguyen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconness Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Nguyen</last_name>
      <email>pnguyen@lroc.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Nguyen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconness Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Nguyen</last_name>
    </contact>
    <contact_backup>
      <last_name>Cesar Vazquez</last_name>
      <phone>(617) 632-9279</phone>
      <email>cvazquez@bidmc.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Nguyen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Blacktown Hospital</name>
      <address>
        <city>Blacktown</city>
        <state>New South Wales</state>
        <zip>2148</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hayden</last_name>
      <phone>+612 8645 5075</phone>
      <email>Amy.Hayden@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Amy Hayden</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Campbelltown Hospital</name>
      <address>
        <city>Campbelltown</city>
        <state>New South Wales</state>
        <zip>2560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Sidhom</last_name>
      <phone>+61 (02) 4634 3000</phone>
      <email>Mark.Sidhom@sswahs.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Sidhom</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chris O'Brien Lifehouse</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nitya Patanjali</last_name>
      <phone>+61 2 8514 0229</phone>
      <email>nitya.patanjali@lh.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Nitya Patanjali</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Genesis Cancer Care Newcastle</name>
      <address>
        <city>Gateshead</city>
        <state>New South Wales</state>
        <zip>2290</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarad Martin</last_name>
      <email>Jarad.martin@calvarymater.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Jarad Martin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gosford Hospital</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <zip>2250</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Kneebone</last_name>
      <phone>+61 (02) 4320 2111</phone>
      <email>Akneebone@nsccahs.health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Kneebone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>Kogarah</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Bucci</last_name>
      <phone>+612 9113 3831</phone>
      <email>Joseph.Bucci@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Bucci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Sidhom</last_name>
      <phone>+61 (02) 9828 3000</phone>
      <email>Mark.Sidhom@sswahs.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Sidhom</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central West Cancer Services</name>
      <address>
        <city>Orange</city>
        <state>New South Wales</state>
        <zip>2800</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Graham Stevens</last_name>
      <phone>+61 (02) 6369 3380</phone>
      <email>graham.stevens@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Graham Stevens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2131</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colin Chen</last_name>
      <email>colin.chen@sesiahs.health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Colin Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Kneebone</last_name>
      <email>andrew.kneebone@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Kneebone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raj Jagavkar</last_name>
      <email>raj.jagavkar@svha.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Raj Jagavkar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tamworth Rural Referral Hospital</name>
      <address>
        <city>Tamworth</city>
        <state>New South Wales</state>
        <zip>2340</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Round</last_name>
      <phone>+61 (02) 6767 7700</phone>
      <email>caroline.round@hnehealth.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Caroline Round</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sydney Adventist Hospital</name>
      <address>
        <city>Wahroonga</city>
        <state>New South Wales</state>
        <zip>2076</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Teh</last_name>
      <email>amy.teh@radiotherapy.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>02 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Amy Teh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Calvary Mater Newcastle</name>
      <address>
        <city>Waratah</city>
        <state>New South Wales</state>
        <zip>2298</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarad Martin</last_name>
      <phone>+61 (02) 4921 1211</phone>
      <email>jarad.martin@calvarymater.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Jarad Martin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hayden</last_name>
      <phone>+61 (02) 9845 5555</phone>
      <email>Amy.Hayden@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Amy Hayden</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wollongong Hospital</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremiah de Leon</last_name>
      <phone>+612 4222 5200</phone>
      <email>jeremiah.de.leon@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Jeremiah de Leon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Genesis Cancer Care Queensland - Wesley and Chermside</name>
      <address>
        <city>Auchenflower</city>
        <state>Queensland</state>
        <zip>4066</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Art Kaminski</last_name>
      <email>art.kaminski@genesiscare.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Art Kaminski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Townsville Hospital</name>
      <address>
        <city>Douglas</city>
        <state>Queensland</state>
        <zip>4814</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alex Tan</last_name>
      <email>alex.tan@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Alex Tan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane &amp; Womens Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4006</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Chan</last_name>
      <phone>+61 (07) 3636 8111</phone>
      <email>philip_chan@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Philip Chan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nambour General Hospital</name>
      <address>
        <city>Nambour</city>
        <state>Queensland</state>
        <zip>4560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcel Knesl</last_name>
      <phone>+61 (07) 5470 6600</phone>
      <email>Marcel.Knesl@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Marcel Knesl</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiation Oncology Mater Centre</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanya Holt</last_name>
      <phone>+61 07 3163 8111</phone>
      <email>tanya.holt@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Tanya Holt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiation Oncology Centre- Gold Coast</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jim Jackson</last_name>
      <email>jim.jackson@roc.team</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Jim Jackson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncology Research Australia</name>
      <address>
        <city>Toowoomba</city>
        <state>Queensland</state>
        <zip>4350</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Khoo</last_name>
      <phone>+61 (07) 4614 5855</phone>
      <email>eric.khoo@roq.net.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Eric Khoo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Genesis Cancer Care Queensland - Tugun and Southport</name>
      <address>
        <city>Tugun</city>
        <state>Queensland</state>
        <zip>4224</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Christie</last_name>
      <email>david.christie@premion.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>David Christie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital Brisbane</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Pryor</last_name>
      <phone>+61 (07) 3176 2111</phone>
      <email>david.pryor@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>David Pryor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raghu Gowda</last_name>
      <email>Raghu.Gowda@health.sa.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Raghu Gowda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Leung</last_name>
      <phone>+61 (08) 8204 5511</phone>
      <email>jleung@adradcentre.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>John Leung</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ashford Cancer Care Research (Adelaide Cancer Centre)</name>
      <address>
        <city>Kurralta Park</city>
        <state>South Australia</state>
        <zip>5037</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Borg</last_name>
      <phone>+61 08 8292 2220</phone>
      <email>mborg@adradcentre.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Borg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marketa Skala</last_name>
      <phone>+61 (03) 6222 8308</phone>
      <email>marketa.skala@dhhs.tas.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Marketa Skala</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peter MacCallum Cancer Centre</name>
      <address>
        <city>Bendigo</city>
        <state>Victoria</state>
        <zip>3550</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Shaw</last_name>
      <email>Mark.Shaw@petermac.org</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Shaw</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peter MacCallum Cancer Centre (Moorabbin Campus)</name>
      <address>
        <city>Bentleigh East</city>
        <state>Victoria</state>
        <zip>3165</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Williams</last_name>
      <phone>(03) 9928 8901</phone>
      <email>Scott.Williams@petermac.org</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Scott Williams</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Health (Box Hill Hospital)</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <zip>3128</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Lim Joon</last_name>
      <phone>+61 1300 342 255</phone>
      <email>Michael.LimJoon@petermac.org</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Lim Joon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Epping Radiation Oncology Centre</name>
      <address>
        <city>Epping</city>
        <state>Victoria</state>
        <zip>3076</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Ng</last_name>
      <phone>+61 03 9409 8000</phone>
      <email>mng@radoncvic.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Ng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Radiation Oncology Centre</name>
      <address>
        <city>Footscray</city>
        <state>Victoria</state>
        <zip>3011</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Guerreri</last_name>
      <phone>+61 03 9319 3200</phone>
      <email>mguerrieri@radoncvic.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Mario Guerreri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Frankston Radiation Oncology Centre</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <zip>3199</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Blakey</last_name>
      <phone>+61 03 9781 8200</phone>
      <email>dblakey@radoncvic.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>David Blakey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Health</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daryl Lim Joon</last_name>
      <phone>+61 (03) 9496 5000</phone>
      <email>Daryl.LimJoon@austin.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Daryl Lim Joon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peter MacCallum Cancer Centre</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Williams</last_name>
      <phone>03 9656 1111</phone>
      <email>Scott.williams@petermac.org</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>02 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Scott Williams</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Epworth HealthCare - Richmond</name>
      <address>
        <city>Richmond</city>
        <state>Victoria</state>
        <zip>3121</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Bowden</last_name>
      <email>pat.bowden@epworth.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Patrick Bowden</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ringwood Radiation Oncology Centre</name>
      <address>
        <city>Ringwood East</city>
        <state>Victoria</state>
        <zip>3135</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Chao</last_name>
      <phone>+61 03 8870 3300</phone>
      <email>mchao@radoncvic.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Chao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunshine Hospital</name>
      <address>
        <city>St Albans</city>
        <state>Victoria</state>
        <zip>3021</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Violet</last_name>
      <email>john.violet@petermac.org</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>John Violet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6149</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tee Sin Lim</last_name>
      <email>tee.lim@genesiscancercare.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Tee Lim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Salzburger Landeskliniken - Universitätsklinikum Salzburg</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greil Richard</last_name>
      <email>evelien.nollet@eortc.be</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Greil Richard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Groeninge Kortrijk- Campus Kennedylaan</name>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Billiet Ignace</last_name>
      <email>evelien.nollet@eortc.be</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Billiet Ignace</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cork University Hospital</name>
      <address>
        <city>Cork</city>
        <state>Co Cork</state>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Kelly</last_name>
      <phone>+353 21 492 2000</phone>
      <email>PaulJ.Kelly@hse.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Kelly</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Galway University Hospital</name>
      <address>
        <city>Galway</city>
        <state>Co Galway</state>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cormac Small</last_name>
      <phone>+353 91 524222</phone>
      <email>Cormac.Small@hse.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Cormac Small</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae University Hospital</name>
      <address>
        <city>Dublin</city>
        <state>Dublin 7</state>
        <zip>Dublin 7</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Maher</last_name>
      <phone>+353 1 803 2000</phone>
      <email>mmaher@materprivate.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Maher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beacon Private Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>Dublin 18</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alina Mihai</last_name>
      <email>Alina.MihaelaMihai@beaconhospital.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Alina Mihai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Private Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>Dublin 7</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Maher</last_name>
      <phone>+353 1 885 8888</phone>
      <email>mmaher@materprivate.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Maher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1142</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chakiath Jose</last_name>
      <phone>+64 9-307 4949</phone>
      <email>CJose@adhb.govt.nz</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Chakiath Jose</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <zip>4170</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Williams</last_name>
      <phone>+64 3-364 0640</phone>
      <email>Stephen.Williams@cdhb.health.nz</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5368</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Steve Williams</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palmerston North Hospital</name>
      <address>
        <city>Palmerston North</city>
        <zip>4442</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Chan</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Donald Chan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Institute Of Oncology</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carman Janka</last_name>
      <email>evelien.nollet@eortc.be</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Carman Janka</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia)</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Villa Salvador</last_name>
      <email>evelien.nollet@eortc.be</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Villa Salvador</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Donostia</name>
      <address>
        <city>Donostia</city>
        <state>Gipuzkoa</state>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ciria SJ Pablo</last_name>
      <email>evelien.nollet@eortc.be</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Ciria SJ Pablo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gomez V Francisco</last_name>
      <email>evelien.nollet@eortc.be</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Gomez V Francisco</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Velindre Hospital</name>
      <address>
        <city>Whitchurch</city>
        <state>Cardiff</state>
        <zip>CF14 2TL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Staffurth</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>John Staffurth</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Southhampton</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Heath</last_name>
      <email>Catherine.Heath@uhs.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Olwyn Deignan</last_name>
      <email>Olwyn.Deignan@icorg.ie</email>
    </contact_backup>
    <investigator>
      <last_name>Catherine Heath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Luke's Hospital</name>
      <address>
        <city>Dublin</city>
        <state>Ireland</state>
        <zip>Dublin 6</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Thirion</last_name>
      <email>pierre@thirion.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre Thirion</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kent and Canterbury Hospital</name>
      <address>
        <city>Canterbury</city>
        <state>Kent</state>
        <zip>CT1 3NG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carys Thomas</last_name>
      <email>carys.thomas@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Carys Thomas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Marsden Hospital</name>
      <address>
        <city>Chelsea</city>
        <state>London</state>
        <zip>SW3 6JJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Khoo</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Vincent Khoo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <state>Scotland</state>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alastair Law</last_name>
      <email>Alastair.Law@nhslothian.scot.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Alastair Law</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal United Hospital Bath</name>
      <address>
        <city>Bath</city>
        <zip>BA1 3NG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Beresford</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Beresford</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Addenbrookes Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olwyn Deignan</last_name>
      <email>Olwyn.Deignan@cancertrials.ie</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61295625000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Yvonne Rimmer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of London Hospital</name>
      <address>
        <city>London</city>
        <zip>NW1 2BU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Payne</last_name>
      <email>heather.payne@ukgateway.net</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+612 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Heather Payne</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guys and St Thomas Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Morriss</last_name>
      <email>stephen.morriss@gstt.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Morriss</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charring Cross Hospital: Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Mangar</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Mangar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital- City Campus</name>
      <address>
        <city>Nottingham</city>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliot Chadwick</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Tu</last_name>
      <phone>+61 2 9562 5000</phone>
      <email>enzarad@ctc.usyd.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Eliot Chadwick</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Ireland</country>
    <country>New Zealand</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.anzup.org.au</url>
    <description>Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group.</description>
  </link>
  <link>
    <url>http://ctc.usyd.edu.au/</url>
    <description>University of Sydney, National Health and Medical Research Council (NHMRC) Clinical Trials Centre.</description>
  </link>
  <link>
    <url>http://www.anzctr.org.au/</url>
    <description>Australian New Zealand Clinical Trials Registry (ANZCTR)</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2015</study_first_submitted>
  <study_first_submitted_qc>May 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2015</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>High risk</keyword>
  <keyword>clinically localised prostate cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Androgens</mesh_term>
    <mesh_term>Nonsteroidal Anti-Androgens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

